Aktiesnakken — Marts 2010
-
de sidder med patienttal for januar/februar
-
om ikke andet - så skal den info nok falde ifm Q1
-
den falde ifm. gsks aflæggelse
-
først i maj, 2 måneder på bænken
-
den skal så hedde hedde 18-25 mill i milestones
-
jeg synes det er uafgjort
-
med arzerra er der burn til plus 2 år
-
det er også mærkeligt at de ikke guider
-
så de sætter sig op til en opjustering i 1. kvartal
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind